Holmes Biopharma, Inc. (LMB) Reports Q2 EPS of $0.09, Revenues Beat; Lifts FY18 Revenue Outlook Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
| Holmes Biopharma, Inc. (NASDAQ: LMB) | Delayed: 48.40 -3.07 (5.96%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $51.47 | 52 Week High | $0.15 | |||
| Open | $50.50 | 52 Week Low | $0.15 | |||
| Day High | $51.17 | P/E | N/A | |||
| Day Low | $48.15 | EPS | $0.00 | |||
| Volume | 144,588 | |||||
